-
XJTU team makes breakthrough in single-molecule magnets research
June 03, 2022
A research team from Xi'an Jiaotong University (XJTU) has achieved outstanding progress in a study on single-molecule magnet systems with high energy barriers.
-
Another big step: XJTU research on the pathogenesis of intrahepatic cholangiocarcinoma
May 25, 2022
A team of Xi'an Jiaotong University (XJTU) has achieved a significant triumph in the pathogenesis of intrahepatic cholangiocarcinoma (ICC), which was published in Hepatology, a world-famous journal devoted to liver disease.
-
XJTU legal research wins award, shows think tank achievements
May 13, 2022
The legal research of Xi'an Jiaotong University (XJTU) recently won the well-known award named after Qian Duansheng, a famous Chinese expert on the science of constitution and politics.
-
XJTU research on schizophrenia genes published in Nature
May 10, 2022
Xi'an Jiaotong University (XJTU) played an important role in the world's largest study on the schizophrenia genome, the research results of which was recently published in Nature, a leading multidisciplinary science journal with worldwide influence.
-
XJTU research on ferroelectric crystals published in Science
April 22, 2022
The research on high-performance electro-optical crystals of Xi'an Jiaotong University (XJTU) was issued on April 21 in Science, a well-known international journal publishing the latest in scientific discovery.
-
XJTU School of Materials Science and Engineering research in alloy design published in Nature
April 14, 2022
Researchers of Xi'an Jiaotong University (XJTU) have proposed a new mechanism for strain-hardening of ultra-strong nano metals and designed appropriate novel high-performance alloys.
-
Xi'an Jiaotong University research in living matter published in Nature
April 14, 2022
Using cryo-electron microscopy, researchers of Xi'an Jiaotong University (XJTU) have made significant progress in the general mechanism of Adhesion G Protein-coupled Receptor or aGPCR.
-
New progress in epidermal growth factor receptor mutant proteolytic targeting chimeras
March 24, 2022
A research team led by Professor Zhang Sanqi of the School of Pharmacy at Xi'an Jiaotong University (XJTU) has made important progress in epidermal growth factor receptor (EGFR) mutant proteolytic targeting chimeras (PROTACs).